JAK3 and acute lymphoblastic leukemia: The expression of JAK3 is also upregulated with a strong activity in the B-lineage acute lymphoblastic leukemia patients [15, 16]; besides, JAK3 protein site mutation is reported to be the regulatory gene in the development of different disorders [7, 17–20].